MECEX
Price
$14.62
Change
+$0.05 (+0.34%)
Updated
Aug 7 closing price
Net Assets
141.54M
RPEBX
Price
$68.50
Change
+$0.16 (+0.23%)
Updated
Aug 7 closing price
Net Assets
156.62B
Interact to see
Advertisement

MECEX vs RPEBX

Header iconMECEX vs RPEBX Comparison
Open Charts MECEX vs RPEBXBanner chart's image
NYLI Epoch Capital Growth
Price$14.62
Change+$0.05 (+0.34%)
VolumeN/A
Net Assets141.54M
American Funds New Perspective R2E
Price$68.50
Change+$0.16 (+0.23%)
VolumeN/A
Net Assets156.62B
MECEX vs RPEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MECEX vs. RPEBX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MECEX is a StrongBuy and RPEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 157B vs. MECEX (142M). RPEBX pays higher dividends than MECEX: RPEBX (0.12) vs MECEX (0.00). MECEX was incepted earlier than RPEBX: MECEX (9 years) vs RPEBX (11 years). MECEX (2.15) is less costly to investors than RPEBX (1.21). MECEX is a more actively managed with annual turnover of: 33.00 vs. RPEBX (24.00). RPEBX has a lower initial minimum investment than MECEX: RPEBX (250) vs MECEX (2500). RPEBX annual gain was more profitable for investors over the last year : 18.92 vs. MECEX (9.02). RPEBX return over 5 years is better than : 34.73 vs. MECEX (2.74).
MECEXRPEBXMECEX / RPEBX
Total Expense Ratio2.151.21178%
Annual Report Gross Expense Ratio2.151.21178%
Fund Existence9 years11 years-
Gain YTD6.25013.46746%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets142M157B0%
Annual Yield % from dividends0.000.12-
Returns for 1 year9.0218.9248%
Returns for 3 years37.5434.78108%
Returns for 5 years2.7434.738%
Returns for 10 yearsN/A75.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS9.390.64
+7.31%
Viatris
VYNE0.380.01
+3.32%
VYNE Therapeutics
PLOW30.770.20
+0.65%
Douglas Dynamics
HLVX2.060.01
+0.49%
HilleVax
CVBF19.03-0.01
-0.05%
CVB Financial Corp